MoonLake Immunotherapeutics (MLTX) EPS (Weighted Average and Diluted) Growth (1y) (2022 - 2026)
MoonLake Immunotherapeutics (MLTX) EPS (Weighted Average and Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 251.11% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -13.31% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 102.51% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -79.34% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -103.05% |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 61.45% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | MoonLake Immunotherapeutics | 1.25 Bn | 888.66 Mn | - | -55.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.56% |
| Dec 31, 2025 | -27.78% |
| Sep 30, 2025 | -96.43% |
| Jun 30, 2025 | -123.08% |
| Mar 31, 2025 | -186.36% |
| Dec 31, 2024 | -620.00% |
| Sep 30, 2024 | -211.11% |
| Jun 30, 2024 | -69.57% |
| Mar 31, 2024 | 4.35% |
| Dec 31, 2023 | 76.74% |
| Sep 30, 2023 | 33.33% |
| Jun 30, 2023 | 32.35% |
| Mar 31, 2023 | 92.74% |
| Dec 31, 2022 | 93.71% |
| Sep 30, 2022 | 89.73% |
| Jun 30, 2022 | 88.28% |
| Mar 31, 2022 | -31,600.00% |